We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.93%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$36.3B
AUM Growth
-$345M
(-0.94%)
Cap. Flow
-$1.99B
Cap. Flow
% of AUM
-5.49%
Top 10 Holdings %
Top 10 Hldgs %
13%
Holding
771
New
91
Increased
196
Reduced
345
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CF Industries
CF
|
+$124M |
| 2 |
Merck
MRK
|
+$118M |
| 3 |
PNC Financial Services
PNC
|
+$109M |
| 4 |
STJ
St Jude Medical
STJ
|
+$108M |
| 5 |
Johnson Controls International
JCI
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$191M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$184M |
| 3 |
American Airlines Group
AAL
|
+$181M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
+$170M |
| 5 |
EMC
EMC CORPORATION
EMC
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.24% |
| 2 | Technology | 11.85% |
| 3 | Financials | 11.02% |
| 4 | Consumer Discretionary | 10.01% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Gen Digital
GEN
$16.3B
| $31.7M | 0.09% |
1,263,759
-661,800
| -34% | -$15.1M |
|
302
Take-Two Interactive
TTWO
$46.3B
| $31.6M | 0.09% |
700,000
+100,000
| +17% | +$4.22M |
|
303
Danaher
DHR
$138B
| $31.6M | 0.09% |
454,003
-728,697
| -62% | -$51.6M |
|
304
Marriott International
MAR
$99B
| $31.5M | 0.09% |
467,488
+322,940
| +223% | +$22.8M |
|
305
PACCAR
PCAR
$70.4B
| $31.4M | 0.09% |
802,532
-224,364
| -22% | -$8.54M |
|
|
CMA
306
DELISTED
Comerica
CMA
| $31.4M | 0.09% |
663,096
+114,600
| +21% | +$5.19M |
|
|
KYNB
307
Kyntra Bio
KYNB
$27.5M
| $31.3M | 0.09% |
60,400
-8,000
| -12% | -$3.77M |
|
308
Baxter International
BAX
$13.8B
| $31.2M | 0.09% |
655,738
-170,200
| -21% | -$8.03M |
|
309
Carnival Corporation Ltd
CCL
$38B
| $30.7M | 0.08% |
629,100
-25,900
| -4% | -$1.2M |
|
|
GNMK
310
DELISTED
GenMark Diagnostics, Inc
GNMK
| $30.7M | 0.08% |
2,599,857
-100,000
| -4% | -$965K |
|
|
ZAYO
311
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $30.5M | 0.08% |
1,025,000
+125,000
| +14% | +$3.62M |
|
312
Boston Properties
BXP
$11.4B
| $30.4M | 0.08% |
222,956
-5,200
| -2% | -$722K |
|
313
Jazz Pharmaceuticals
JAZZ
$16.2B
| $30.4M | 0.08% |
+250,000
| New | +$33.7M |
|
314
Centene
CNC
$30.1B
| $29.8M | 0.08% |
889,000
-120,400
| -12% | -$4.18M |
|
315
Kennametal
KMT
$2.54B
| $29.8M | 0.08% |
+1,025,352
| New | +$27.1M |
|
|
POT
316
DELISTED
Potash Corp Of Saskatchewan
POT
| $29.4M | 0.08% |
1,800,000
+1,100,000
| +157% | +$18.2M |
|
|
OPLN
317
Openlane
OPLN
$4.29B
| $29.4M | 0.08% |
1,797,881
-1,453,100
| -45% | -$23.2M |
|
318
Monster Beverage
MNST
$95.5B
| $29.2M | 0.08% |
1,191,666
-48,600
| -4% | -$1.26M |
|
319
Occidental Petroleum
OXY
$55.6B
| $28.6M | 0.08% |
392,300
-185,700
| -32% | -$13.9M |
|
|
UTEK
320
DELISTED
Ultratech Inc.
UTEK
| $28.4M | 0.08% |
1,232,278
-196,247
| -14% | -$4.77M |
|
321
International Paper
IP
$22.8B
| $28.3M | 0.08% |
622,926
-25,978
| -4% | -$1.15M |
|
|
XLNX
322
DELISTED
Xilinx Inc
XLNX
| $28M | 0.08% |
514,900
+134,900
| +36% | +$6.93M |
|
323
Amphenol
APH
$197B
| $27.7M | 0.08% |
1,705,104
+326,000
| +24% | +$4.95M |
|
|
CSC
324
DELISTED
Computer Sciences
CSC
| $27.4M | 0.08% |
+525,000
| New | +$25.4M |
|
325
Henry Schein
HSIC
$9.7B
| $27.3M | 0.08% |
427,890
+115,005
| +37% | +$7.63M |
|
Similar funds
Adage Capital Partners's Q3 2016 Portfolio in Review
As of Q3 2016, Adage Capital Partners held 771 positions worth $36.3B, down 0.94% from $36.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Adage Capital Partners withdrew a net $1.99B in Q3 2016, closing 92 positions and reducing 345 holdings. Its most notable exit was MEDIVATION, INC., an estimated $170M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in Kinder Morgan worth $64.8M.
- Adage Capital Partners's largest Q3 2016 buy was Kinder Morgan: 2,802,197 shares worth $64.8M.
- Adage Capital Partners added most to CF Industries in Q3 2016, an estimated $124M increase.
- Adage Capital Partners's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $191M.
- Adage Capital Partners fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $170M.
- Adage Capital Partners's ten largest holdings make up 13% of its $36.3B portfolio in Q3 2016.
- Adage Capital Partners opened 91 new positions and closed 92 in Q3 2016.
- Adage Capital Partners's portfolio value fell 0.94% quarter-over-quarter to $36.3B.
Based on Adage Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.